Cargando…
Tocolysis in the management of preterm prelabor rupture of membranes at 22–33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM)
BACKGROUND: Preterm prelabor rupture of membranes (PPROM) before 34 weeks of gestation complicates 1% of pregnancies and accounts for one-third of preterm births. International guidelines recommend expectant management, along with antenatal steroids before 34 weeks and antibiotics. Up-to-date eviden...
Autores principales: | Lorthe, Elsa, Kayem, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425321/ https://www.ncbi.nlm.nih.gov/pubmed/34496799 http://dx.doi.org/10.1186/s12884-021-04047-2 |
Ejemplares similares
-
Subsequent Pregnancy after Preterm Prelabor Rupture of Membranes before 27 Weeks' Gestation
por: van der Heyden, Jantien L., et al.
Publicado: (2013) -
Antibiotic prophylaxis in preterm premature rupture of membranes at 24–31 weeks’ gestation: Perinatal and 2‐year outcomes in the EPIPAGE‐2 cohort
por: Lorthe, Elsa, et al.
Publicado: (2022) -
Unit policies regarding tocolysis after preterm premature rupture of membranes: association with latency, neonatal and 2-year outcomes (EPICE cohort)
por: Lorthe, Elsa, et al.
Publicado: (2020) -
Cervical Microbiota in Women with Preterm Prelabor Rupture of Membranes
por: Kacerovsky, Marian, et al.
Publicado: (2015) -
Intraamniotic Inflammation in Women with Preterm Prelabor Rupture of Membranes
por: Musilova, Ivana, et al.
Publicado: (2015)